We are live on ! Find out more
CNTB icon

Connect Biopharma Holdings

42 hedge funds and large institutions have $32.4M invested in Connect Biopharma Holdings in 2026 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,680% more capital inflows, than outflows

Capital inflows: $11.8M | Capital outflows: $663K

400% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 3

129% more call options, than puts

Call options by funds: $526K | Put options by funds: $230K

40% more funds holding

Funds holding: 30 → 42 (+12)

13% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 8

7.66% more ownership

Funds ownership: 15.15% → 22.8% (+7.7%)

Holders
42
Holders Change
+12
Holders Change %
+40%
% of All Funds
0.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
9
Reduced
8
Closed
3
Calls
$526K
Puts
$230K
Net Calls
+$296K
Net Calls Change
-$215K

CNTB Hedge Fund Activity: Q1 2026 in Review

42 of the 8,241 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q1 2026, worth a combined $32.4M — up 36% from $23.9M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CNTB positions and 3 closed out — a net gain of 12 holders — while 9 added to existing stakes and 8 trimmed.

The largest buyer was 683 Capital Management, opening a new position worth an estimated $2.35M. The largest seller was OMERS Administration Corp, exiting entirely with an estimated $228K sold.

  • 42 institutional investors held Connect Biopharma Holdings (CNTB) as of Q1 2026, up from 30 in Q4 2025.
  • Funds reported $32.4M of Connect Biopharma Holdings stock for Q1 2026, up 36% quarter-over-quarter.
  • 15 funds opened new Connect Biopharma Holdings positions in Q1 2026 and 3 closed out, a net change of +12 holders.
  • The largest Connect Biopharma Holdings buyer in Q1 2026 was 683 Capital Management, an estimated $2.35M added.
  • The largest Connect Biopharma Holdings seller in Q1 2026 was OMERS Administration Corp, an estimated $228K sold.

Based on aggregated 13F filings for Q1 2026.